Inspiration Hlt Regulatory News (IHC)

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

Post Period Trading Update and Notice of Results

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that, following the close of the financial year, the Group is expecting to exceed market expectations and to report Group revenues for the financial year ended 31 January 2022 of approximately £41.0 million representing an increase of 10.9% compared to the prior financial year. Adjusted EBITDA* is expected to be not less than £6.2 million, representing growth of 10.5% over the prior financial year, which includes a one-off receipt of £0.2 million. Operating profit is similarly ahead of market expectations.

The Company will be announcing its results for the financial year ended 31 January 2022 on Wednesday 4 May 2022.

Neil Campbell, Chief Executive Officer, commented: "I am very pleased to announce that the Group has performed exceptionally strongly in what was a difficult trading environment with many new problems arising out of the ongoing Covid-19 pandemic such as supply chain issues and cost increases. The Group is now well integrated, demand for our products remains high around the world and we enter our new financial year with confidence.

I'm also pleased to report that we remain on track for the completion of our new manufacturing, tech support and R&D facility in Croydon which is expected to become operational in April 2022. This new facility will integrate many of our operations under one roof and has been designed to ensure an ultra-low environmental impact with the building utilising the very latest in energy saving technologies to achieve this."

* Earnings before interest, tax, depreciation, amortisation, share based payments and non-trading items.

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at www.inspirationhealthcaregroup.plc.uk